bevyxxa
bevyxxa: sourced relationships with 1 company · 1 FDA decision.
bevyxxa evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect bevyxxa to PTLA; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could bevyxxa → PTLA affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
prevention of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| PORTOLA PHARMACEUTICALS INC (PTLA) prevention of venous thromboembolism (VTE) in adult patients… | Approved |
Frequently asked questions
Which companies have sourced relationships with bevyxxa?
bevyxxa has dated SEC/FDA relationship records for PORTOLA PHARMACEUTICALS INC.
What is bevyxxa's latest FDA decision?
The most recent tracked FDA decision for bevyxxa is Approval, dated June 23, 2017.